- /
- Supported exchanges
- / US
- / SCNLF.PINK
Scancell Holdings plc (SCNLF PINK) stock market data APIs
Scancell Holdings plc Financial Data Overview
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Scancell Holdings plc data using free add-ons & libraries
Get Scancell Holdings plc Fundamental Data
Scancell Holdings plc Fundamental data includes:
- Net Revenue: 4 711 K
- EBITDA: -12 963 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-04-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Scancell Holdings plc News
New
Endeavour Mining, Atlantic Lithium, Scancell, hVIVO, Active Energy, Valereum - Small Cap Snapshot
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF, FRA:6E2) has hit full-year 2025 guidance and declared a record $200 million second-half dividend. Production topped 1.2 million ounces, debt fell s...
Scancell, Pan African Resources, Thor Explorations, Oriole Resources, Active Energy, Quantum Helium
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) has received FDA clearance for a Phase 3 melanoma trial of iSCIB1+. Phase 2 data showed better progression-free survival, helped by a marker to sel...
Scancell Holdings "well-financed" and continuing to pursue deals
London, UK --News Direct-- Scancell Holdings PLC Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)'s chief executive Professor Lindy Durrant speaks to Thomas Warner from Proactive to provide an update on t...
Investing in Scancell Holdings (LON:SCLP) three years ago would have delivered you a 146% gain
It hasn't been the best quarter for Scancell Holdings plc (LON:SCLP) shareholders, since the share price has fallen 21% in that time. But in three years the returns have been great. In three years the...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.